Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,704 | 3,195 | N/A | 1,198 | 679 |
| Marketable Securities | N/A | N/A | N/A | 118 | 162 |
| Receivables | N/A | N/A | N/A | 2,081 | 1,711 |
| Other current assets | 0 | 0 | 0 | 800 | 874 |
| TOTAL | $54,261 | $3,565 | $N/A | $4,677 | $3,861 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1,394 | N/A | 634 | 568 |
| Intangibles | 0 | 0 | 0 | 707 | 899 |
| Other Non-Current Assets | 293 | 422 | 0 | 7,214 | 7,178 |
| TOTAL | $293 | $1,816 | $N/A | $8,555 | $8,645 |
| Total Assets | $54,554 | $5,381 | $N/A | $13,232 | $12,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 56 | 317 |
| Accounts payable and accrued liabilities | 909 | 342 | 0 | 245 | 301 |
| Accrued Expenses | 535 | 423 | N/A | 909 | 741 |
| Other current liabilities | 962 | 173 | N/A | 559 | 679 |
| TOTAL | $2,406 | $1,060 | $N/A | $7,277 | $7,306 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 0 | 56 |
| Deferred Revenues | N/A | N/A | N/A | 4,537 | 4,276 |
| Other Non-Current Liabilities | 1,920 | 764 | 0 | 5,566 | 5,638 |
| TOTAL | $1,920 | $774 | $N/A | $5,566 | $5,693 |
| Total Liabilities | $4,326 | $1,834 | $N/A | $12,843 | $12,999 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 10,752 | 10,617 |
| Common Shares | N/A | 0 | N/A | 1,075 | 1,070 |
| Retained earnings | -91,447 | -38,034 | N/A | -23,346 | -24,091 |
| Other shareholders' equity | 139,576 | 40,095 | 0 | -370 | -378 |
| TOTAL | $50,228 | $3,547 | $N/A | $389 | $-493 |
| Total Liabilities And Equity | $54,554 | $5,381 | $0 | $13,232 | $12,506 |